ABSTRACT. Polymyxin B (PxB) is a polycationic peptide antibiotic produced by gram-positive bacteria Bacillus polymyxia, and is highly selective against gram-negative organisms. In the present work we have studied the interaction of PxB and PxB-nonapeptide (NF' ), with lipid monolayers of a lipidic extract from Escherichia coli, a bacteria susceptible to PxB. Kinetics of insertion of both peptides at different surface pressures are compared. Also, the effect of peptides on the phase behaviour of the monolayers is determined from the compression isotherms.
INTRODUCTION
Polymyxin B (P*) (figure l-a) is a cyclic amphipathic decapeptide with five positively charged side chains and an acyl chain at the N-terminus [l] . It is produced by Grampositive Paenibacillus polymyxa and it is highly selective against Gram-negative organisms. Polyrnyxins have been in prevalent use for several decades, however there is no indication of the antibiotic resistance in clinical isolates. They act on membranes, yet the antibacterial mechanism is not stablished. Binding of PxB to surface lipolysaccharides, and consequent disruption of the outer membrane of Gram-negative organisms [2] to permit their entry into periplasmatic space of gram-negative organisms, is a necessary but not a sufficient condition for the antimicrobial effect; PxB nonapeptide (NP) (figure I-b) disrupts the outer membrane but it is not an antibiotic ionophores. They induce leakage of the cytoplasmic contents at significantly higher concentrations than the antimicrobial concentrations [4] .
In the present work we have studied the interaction of PxB and PxB-nonapeptide (NP),
with lipid monolayers of a lipidic extract from Escherichia coli, a bacteria susceptible to PxB. Kinetics of insertion of both peptides at different surface pressures are compared.
Also, the effect of peptides on the phase behaviour of the monolayers is determined from the compression isotherms.
MATERIALS AND METHODS

Materials
Polymyxyn B (PxB) and PxB nonapeptide were purchased from Sigma Aldrich (St.
Louis, Mo,USA). E. coli total lipid extract (573% phosphatidylethanolamine (PE), 15,1% of phophatidylglycerol (PG), 9,8% cardiolipin (CL) and 17,0% others) was obtained from Avanti Polar Lipids (Alabaster, Al. USA).
Spreading solvent was chloroform. Lipid films were prepared from chloroform solutions of approximate concentration of 1 mg.ml-l. Monolayers were spread on 10 mM TRIS (trisbydroxymethyl]amino-methane) buffer subphase, pH = 8.0.
Methods
Monolayer studies were performed on a MMA technology Langmuir film balance equipped with a Wilhemy plate, a pression sensor PS4, a ST 9000 tensiometer and a software trough. The temperature of the experiments was always 21k0.5 'C.
Suface activity measurements
These experiments were performed in a cylindrical trough (70 m1 volume) with mechanical stirring. The trough was filled with 10 mM TRIS buffer solution, pH 8,0, and increasing volumes of concentrate antibiotic solutions were injected directly underneath through a lateral hole. Pressure increase was recorded continuously for 120 min. Each m was carried out in triplicate and reproducibility was usually within 0.1-
Penetration kinetics
The same conditions mentioned above were used but for this case a lipid monolayer was present at the air-water interface. Monolayers of E. coli extract were formed spreading lipidic solutions in chloroform to reach a required initial pressure of 5, 10, 20 or 32 m~. m " .
Compression isotherms
The compression isotherms were carried on a PTFE trough of surface area 525 cm2 and volume 240 cm3. Monolayers of E. coli extract were formed by applying small drops of the spreading solutions on the 10 mM TRIS buffer subphase (pH=8.0) with a microsyringe (Hamilton CO, Reno, USA). After five minutes, the monolayers were continuously compressed (symetrical compression) with an area reduction rate of 80 cm2.min-l. The films were compressed up to their collapse pressure. Each run was repeated three times and standard deviation was typically < 0.5%. where R is 8.31 X 105 mN . cm. K-'. mol-l, T is the temperature (K) , AII is the surface pressure increase and c is the molar concentration and are given in table 1. Surface pressure increase at 80 minutes from PxB injection; C Surface excess.
JOURNAL DE PHYSIQUE IV
Penetration kinetics
After injection of PxB beneath monolayers a clear insertion process was detected (fig. 2 ).
As expected, there was a strong dependence of the maximum surface increase achieved 
Compression isotherms
The studies performed using compression isotherms let us to check the ability of the E.
coli lipid extract to produce a stable monolayer with pressure collapse at 49 m~.m''.
The monolayer compressibility indicates that for area values until 360 A .molecl the monolayer present a gas phase behaviour and for minor values are the liquid-expanded state until to collapse pressure. The presence of PxB in the subphase at 2pM
concentration produced an expansion of the monolayer indicative that an insertion process is produced. The collapse pressure remains constant at 49 r n~. m~' . Similar behaviour was described before for derivative lipopeptidic antigens of hepatitis A viruses [5] . When NP at the same concentration was injected in the subphase no changes in the E. coli lipid extract monolayer were observed. These results are When NP at 2 was present in the subphase the compressibility of the monolayer are the same as E. coli lipid extract (-).
